Results 211 to 220 of about 6,111 (249)
Some of the next articles are maybe not open access.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2006
Pityriasis rubra pilaris is a chronic, papulosquamous dermatosis of unknown etiology. Oral mucosal involvement of this condition is rare with only 3 previously reported cases in the English literature. A case of a 68-year-old man with pityriasis rubra pilaris with involvement of tongue and palate is presented.
Luis Edmundo, Martinez Calixto +4 more
openaire +2 more sources
Pityriasis rubra pilaris is a chronic, papulosquamous dermatosis of unknown etiology. Oral mucosal involvement of this condition is rare with only 3 previously reported cases in the English literature. A case of a 68-year-old man with pityriasis rubra pilaris with involvement of tongue and palate is presented.
Luis Edmundo, Martinez Calixto +4 more
openaire +2 more sources
Photoaggravated pityriasis rubra pilaris
Photodermatology, Photoimmunology & Photomedicine, 2005Pityriasis rubra pilaris (PRP) is a rare papulosquamous condition with an estimated incidence of one in 35 000 to one in 50 000. Psoralen and ultraviolet A (UVA) therapy has been used in its treatment but some patients are reported to be clinically photosensitive. We describe the photoinvestigation of a patient with PRP in whom sensitivity to broadband
Evangelou, G. +3 more
openaire +3 more sources
Archives of Dermatology, 1984
To the Editor.— The recent report by Murray et al 1 on the occurrence of hypertriglyceridemia in two middle-aged men during and after unsuccessful treatment of pityriasis rubra pilaris (PRP) with high-dose vitamin A (retinol) was of great interest.
openaire +2 more sources
To the Editor.— The recent report by Murray et al 1 on the occurrence of hypertriglyceridemia in two middle-aged men during and after unsuccessful treatment of pityriasis rubra pilaris (PRP) with high-dose vitamin A (retinol) was of great interest.
openaire +2 more sources
EMC - Dermatología, 2015
Pityriasis rubra pilaris is a rare heterogeneous dermatosis associating three clinical signs to different degrees: follicular corneal papules, reddish-orange palmoplantar keratoderma and erythematosquamous lesions that may in some cases be very extensive, interspersed with patches of healthy skin.
Sandrine, Quenan, Emmanuel, Laffitte
openaire +3 more sources
Pityriasis rubra pilaris is a rare heterogeneous dermatosis associating three clinical signs to different degrees: follicular corneal papules, reddish-orange palmoplantar keratoderma and erythematosquamous lesions that may in some cases be very extensive, interspersed with patches of healthy skin.
Sandrine, Quenan, Emmanuel, Laffitte
openaire +3 more sources
Rapid clearance of extensive juvenile pityriasis rubra pilaris with ixekizumab
Pediatric dermatologyJuvenile pityriasis rubra pilaris is a rare inflammatory skin disorder currently without any FDA‐approved treatments, and lesions can be refractory to conventional treatment with topical corticosteroids, methotrexate, and oral retinoids.
Eun Jae Kim, Kristen Corey, Yasin Damji
semanticscholar +1 more source
Resolution of Pityriasis rubra pilaris induced ectropion with oral dexamethasone. A case report
OrbitAn 82-year-old male presented with generalised Pityriasis rubra pilaris (PRP) managed initially by dermatology team. The patient did not respond to first- and second-line treatment, including oral acitretin, steroid creams, and methotrexate, and ...
Ourania Fydanaki +3 more
semanticscholar +1 more source
Archives of Dermatology, 1970
Six adult men with severe and disabling pityriasis rubra pilaris (PRP) were treated with methotrexate by intermittent intravenous, intermittent intramuscular, intermittent weekly oral, and long-term daily oral administration. The most efficacious method was found to be long-term daily oral administration of methotrexate, alternating 5 mg one day and 2 ...
openaire +1 more source
Six adult men with severe and disabling pityriasis rubra pilaris (PRP) were treated with methotrexate by intermittent intravenous, intermittent intramuscular, intermittent weekly oral, and long-term daily oral administration. The most efficacious method was found to be long-term daily oral administration of methotrexate, alternating 5 mg one day and 2 ...
openaire +1 more source
American Journal of Clinical Dermatology, 2023
T. Joshi, Madeleine Duvic
semanticscholar +1 more source
T. Joshi, Madeleine Duvic
semanticscholar +1 more source
(Juvenile) Pityriasis rubra pilaris
International Journal of Dermatology, 2006Virendra N, Sehgal, Govind, Srivastava
openaire +4 more sources